Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 2:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 54 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: None ( observational study ) Clear all

Conditions: Balance Assessment, Falls, Plantar Sensation
Interventions: None AHT; Other
Lead sponsor: RxFunction Inc.; Industry
Eligibility: 20 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Lower Urinary Tract Symptoms
Interventions: None- Observational Study; Other
Lead sponsor: Arbor Research Collaborative for Health; Other
Eligibility: 18 Years and older
Enrollment: 515 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 6
States / cities: Chicago, Illinois • Iowa City, Iowa • Ann Arbor, Michigan + 3 more

Conditions: Breast Cancer, Neurocognitive Impairment, Quality of Life
Interventions: Neurocognitive impairment observation; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 21 Years and older · Female only
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Rett Syndrome
Interventions: None interventional; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 99 Years
Enrollment: 20 participants
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Body Dysmorphic Disorders
Interventions: None, observational study only (no interventions); Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Fibrodysplasia Ossificans Progressiva (FOP)
Interventions: Not listed
Lead sponsor: The International FOP Association; Other
Eligibility: Not listed
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2040
U.S. locations: 1
States / cities: North Kansas City, Missouri

Conditions: Non-Small Cell Lung Cancer
Interventions: None (Observational Study); Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 23
States / cities: Los Angeles, California • Denver, Colorado • Golden, Colorado + 18 more

Conditions: Body Mass Index
Interventions: None, cohort studies; Other
Lead sponsor: Tufts University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 602 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Asthma
Interventions: None (observational study); Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 8,681 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Healthy
Interventions: N/A: SKyRoCKeT is an observational study; Other
Lead sponsor: University of North Carolina, Charlotte; Other
Eligibility: 6 Years to 20 Years
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Lower Urinary Tract Symptoms
Interventions: None-observational, Magnetic Resonance Imaging (MRI), Multimodal Automated Sensory Testing System, Auditory Sensitivity Test; Other · Procedure
Lead sponsor: Arbor Research Collaborative for Health; Other
Eligibility: 18 Years and older
Enrollment: 1,879 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 6
States / cities: Chicago, Illinois • Iowa City, Iowa • Ann Arbor, Michigan + 3 more

Conditions: Thermoregulation
Interventions: None-placebo; Other
Lead sponsor: United States Army Research Institute of Environmental Medicine; Federal
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Fort Novosel, Alabama • Fort Jackson, South Carolina

Conditions: Tourette Syndrome, Obsessive-Compulsive Disorder, Sensory Disorders
Interventions: None - observational study; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Frontotemporal Degeneration, Progressive Supranuclear Palsy, Multiple System Atrophy
Interventions: None-Observation Only; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 997 participants
Timeline: 2003 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Immunoglobulin A Nephropathy
Interventions: No intervention, Other treatment, Iptacopan, Atrasentan; Other
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer
Interventions: None (Observational Study); Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 40
States / cities: Mobile, Alabama • Chandler, Arizona • Little Rock, Arkansas + 36 more

Conditions: Hypertrophic Cardiomyopathy
Interventions: None - this is an observational study; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 65 Years
Enrollment: 2,750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2025
U.S. locations: 17
States / cities: New Haven, Connecticut • Chicago, Illinois • Baltimore, Maryland + 10 more

Conditions: Wound Infection
Interventions: There is no intervention for this study; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 14 Years to 50 Years · Female only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Atrial Fibrillation
Interventions: None/Observational Studies; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 15 Years and older
Enrollment: 155 participants
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Tourette Syndrome
Interventions: None - observational study; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Asthma
Interventions: None (Observational study); Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 4,060 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Communication
Interventions: None. This is an observational study; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 597 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Autism Spectrum Disorder
Interventions: None--observational; Other
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 8 Years to 12 Years
Enrollment: 201 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Advanced Ovarian Cancer
Interventions: None (Observational Study); Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 7
States / cities: Tampa, Florida • Shreveport, Louisiana • Annapolis, Maryland + 4 more

Search by objective public record fields.

How's Your Balance?

Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study

Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty

Cognitive Function in Rett Syndrome During Trofinetide Treatment

Understanding Daily Changes in BDD Risk Using Smartphones

The Fibrodysplasia Ossificans Progressiva (FOP) Registry

Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD

Epigenomic and Metabolomic Signatures of APOA2 Gene by Saturated Fat Interaction

QUARTZ: Comparative Effectiveness of Switching From Albuterol to Albuterol/Budesonide Versus Adding Low-dose ICS or LTRA to Albuterol

The SKyRoCKeT Study

Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study

Physiological Responses to Heat Stress During High-risk Events

Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder

Cognitive Impairement In Frontotemporal Dementia

A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US

An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

Use of Insorb Absorbable Vicryl Staples in Skin Closure for Cesarean Section

Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation

Longitudinal Impact of Stressors in Adults With Tourette Syndrome

GRANITE: Airsupra Effectiveness in the Real World

Trial of Strategies to Communicate Genetic Information to Different Ethnic Subpopulations

A Novel Framework for Impaired Imitation in ASD

A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer